R.G. Niederhoffer Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

R.G. Niederhoffer Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,700	Closed	-$654K	–	29
2019 Q1	$654K	Buy	+13,700	New	+$682K	5.95%	7
2017 Q2	–	Sell	-13,100	Closed	-$713K	–	21
2017 Q1	$713K	Buy	+13,100	New	+$719K	4.59%	8
2016 Q4	–	Sell	-5,100	Closed	-$275K	–	6
2016 Q3	$275K	Sell	5,100 -4,300	-46%	-$276K	1.33%	23
2016 Q2	$691K	Buy	+9,400	New	+$664K	4.38%	8

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

R.G. Niederhoffer Capital Management's BMY Position: Q2 2019 in Review

R.G. Niederhoffer Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 13,700 shares — an estimated $654K sold.

R.G. Niederhoffer Capital Management first reported a position in BMY in Q2 2016 and held it in 4 quarters. The position peaked at $713K in Q1 2017. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

R.G. Niederhoffer Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
R.G. Niederhoffer Capital Management sold 13,700 Bristol-Myers Squibb shares in Q2 2019, an estimated $654K.
R.G. Niederhoffer Capital Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 4 quarters.
R.G. Niederhoffer Capital Management's Bristol-Myers Squibb position peaked at $713K in Q1 2017.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.